CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -88.39 Thousand | -180.43 Thousand | -2.08 Million | -4.36 Million | -6.75 Million |
| Net Income | - | -1.81 Million | -173.4 Thousand | -5.13 Million | -7.44 Million | -6.75 Million |
| Depreciation & Amortization | - | 248.00 | 232.00 | 234.00 | 239.00 | 217.09 |
| Deferred income taxes | - | 1.17 Million | - | - | - | - |
| Stock-based compensation | - | -43.15 Thousand | -247.62 Thousand | 741.84 Thousand | 1.23 Million | 262.55 Thousand |
| Change in working capital | - | 608.71 Thousand | 194.15 Thousand | 2.17 Million | 1.04 Million | -187.08 Thousand |
| Other non-cash items | - | -9353.00 | 46.2 Thousand | 138.49 Thousand | 796.88 Thousand | 6.75 Million |
| Investing Cash Flow | - | - | - | - | -931.94 Thousand | -1234.99 |
| Investments in PPE | - | - | - | - | - | -1234.99 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -884.41 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -931.94 Thousand | 1234.99 |
| Financing Cash Flow | - | 197.77 Thousand | 180.64 Thousand | 2.13 Million | 4.92 Million | 7.02 Million |
| Debt repayment | - | -106.82 Thousand | -180.64 Thousand | -110.06 Thousand | -771.95 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 2.02 Million | - | - |
| Common Stock Issuance | - | 90 Thousand | - | 2.02 Million | 4.02 Million | 7.05 Million |
| Other Financing Activities | - | 214.6 Thousand | - | 217.62 Thousand | 1.66 Million | 6.7 Million |
| Accounts receivables | - | 11.33 Thousand | -4236.57 | 21.28 Thousand | -20.76 Thousand | -20.54 Thousand |
| Accounts payables | - | 86.96 Thousand | 485.93 Thousand | 258.55 Thousand | 395.56 Thousand | - |
| Inventory | - | -11.33 Thousand | 4236.57 | -21.28 Thousand | - | - |
| Other working capital | - | 521.75 Thousand | -291.77 Thousand | 1.91 Million | 648.33 Thousand | -166.53 Thousand |
| Cash at beginning of period | 94.28 Thousand | 3448.00 | 3233.00 | 74.74 Thousand | 463.53 Thousand | 97.85 Thousand |
| Cash at end of period | 94.28 Thousand | 94.41 Thousand | 3448.00 | 3233.00 | 74.74 Thousand | 272.26 Thousand |
| Capital Expenditure | - | - | - | - | - | -1234.99 |
| Effect of forex changes on cash | - | -18.41 Thousand | - | -118.56 Thousand | -20.31 Thousand | 119.78 Thousand |
| Net cash flow / Change in cash | - | 90.96 Thousand | 215.00 | -71.5 Thousand | -388.78 Thousand | 174.4 Thousand |
| Free Cash Flow | - | -88.39 Thousand | -180.43 Thousand | -2.08 Million | -4.36 Million | -6.75 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | -258.59 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 6585.00 |
| Change in working capital | - | - | - | - | - | 72.05 Thousand |
| Other non-cash items | - | - | - | - | - | 10.12 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | 12.01 Thousand |
| Debt repayment | - | - | - | - | - | -11.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 365.71 |
| Other Financing Activities | - | - | - | - | - | 22.85 Thousand |
| Accounts receivables | - | - | - | - | - | -239.99 |
| Accounts payables | - | - | - | - | - | -24.22 Thousand |
| Inventory | - | - | - | - | - | 239.99 |
| Other working capital | - | - | - | - | - | 96.28 Thousand |
| Cash at beginning of period | - | - | - | 94.28 Thousand | 4470.98 | 30.23 Thousand |
| Cash at end of period | - | - | - | 94.28 Thousand | 4470.98 | 4503.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | 132.08 Thousand |
| Net cash flow / Change in cash | - | - | - | - | - | -25.73 Thousand |
| Free Cash Flow | - | - | - | - | - | -169.83 Thousand |
6916
CASI
2389
LBTL
BRN
4120